| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:31059536; PMID:38211720 |
| GO:0000085 | Mitotic g2 phase | Affects phenotype | PMID:38211720 |
| GO:0000278 | Mitotic cell cycle | Affects phenotype | PMID:31059536 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:35395335 |
| GO:0001541 | Ovarian follicle development | Affects phenotype | PMID:36464114; PMID:39938710 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:30675821 |
| GO:0001553 | Luteinization | Decreases phenotype | PMID:30675821 |
| GO:0001649 | Osteoblast differentiation | Decreases phenotype | PMID:34850234 |
| GO:0001958 | Endochondral ossification | Decreases phenotype | PMID:34850234 |
| GO:0002062 | Chondrocyte differentiation | Decreases phenotype | PMID:34850234 |
| GO:0002176 | Male germ cell proliferation | Decreases phenotype | PMID:37216864 |
| GO:0002253 | Activation of immune response | Increases phenotype | PMID:39151878 |
| GO:0003300 | Cardiac muscle hypertrophy | Increases phenotype | PMID:37611474 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:33662508 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:35395335; PMID:39059691 |
| GO:0005757 | Mitochondrial permeability transition pore complex | Increases phenotype | PMID:33662508 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:37094511 |
| GO:0006096 | Glycolytic process | Increases phenotype | PMID:37094511 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:28858478; PMID:29575470 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:36464114 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:37094511 |
| GO:0006523 | Alanine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006537 | Glutamate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006542 | Glutamine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006545 | Glycine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:31596606; PMID:36632902 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:36632902 |
| GO:0006633 | Fatty acid biosynthetic process | Affects phenotype | PMID:30145421 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:36632902 |
| GO:0006695 | Cholesterol biosynthetic process | Decreases phenotype | PMID:30145421 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:28259788; PMID:37094511 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:29079494 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:30590302; PMID:32508751; PMID:33662508; PMID:34748853 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:27633978; PMID:31207516; PMID:32244372; PMID:32244372 |
| GO:0006997 | Nucleus organization | Affects phenotype | PMID:36625514 |
| GO:0007010 | Cytoskeleton organization | Affects phenotype | PMID:27633978; PMID:36625514 |
| GO:0007040 | Lysosome organization | Decreases phenotype | PMID:33662508 |
| GO:0007049 | Cell cycle | Affects phenotype | PMID:27633978 |
| GO:0007128 | Meiotic prophase i | Affects phenotype | PMID:36464114 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:36098747; PMID:37216864 |
| GO:0007340 | Acrosome reaction | Increases phenotype | PMID:32508751 |
| GO:0007566 | Embryo implantation | Decreases phenotype | PMID:38043716 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:36632902 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:36632902 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:39938710 |
| GO:0008219 | Cell death | Affects phenotype | PMID:31059536; PMID:33662508; PMID:36625514 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:26435001; PMID:37094511; PMID:37182577; PMID:38003411 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:24349450; PMID:28591870; PMID:29093337; PMID:30099086 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:29555536; PMID:31981723; PMID:32763284; PMID:34174261; PMID:39059691 |
| GO:0008380 | Rna splicing | Affects phenotype | PMID:36464114 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:39938710 |
| GO:0008610 | Lipid biosynthetic process | Increases phenotype | PMID:30408883 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009094 | L-phenylalanine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009099 | Valine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009437 | Carnitine metabolic process | Affects phenotype | PMID:37094511 |
| GO:0010613 | Positive regulation of cardiac muscle hypertrophy | Increases phenotype | PMID:31981723 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:27998958 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:39059691 |
| GO:0010972 | Negative regulation of g2/m transition of mitotic cell cycle | Increases phenotype | PMID:35940389 |
| GO:0016042 | Lipid catabolic process | Affects phenotype | PMID:33662508; PMID:35605789 |
| GO:0016525 | Negative regulation of angiogenesis | Increases phenotype | PMID:38043716 |
| GO:0016887 | Atp hydrolysis activity | Decreases phenotype | PMID:29079494 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:29079494 |
| GO:0019413 | Acetate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0019432 | Triglyceride biosynthetic process | Decreases phenotype | PMID:30145421 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:37094511 |
| GO:0030041 | Actin filament polymerization | Decreases phenotype | PMID:33662508 |
| GO:0030168 | Platelet activation | Increases phenotype | PMID:33662508 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:37023647 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:36190352 |
| GO:0030879 | Mammary gland development | Increases phenotype | PMID:30102602 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:34174261 |
| GO:0031914 | Negative regulation of synaptic plasticity | Increases phenotype | PMID:34134381 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:35395335 |
| GO:0032776 | Dna methylation on cytosine | Affects phenotype | PMID:36464114 |
| GO:0032869 | Cellular response to insulin stimulus | Affects phenotype | PMID:34186270 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:27473340; PMID:29093337; PMID:31388671 |
| GO:0033327 | Leydig cell differentiation | Decreases phenotype | PMID:36098747; PMID:37216864 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:28259788; PMID:36632902 |
| GO:0035037 | Sperm entry | Increases phenotype | PMID:32508751 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:37023647 |
| GO:0035641 | Locomotory exploration behavior | Decreases phenotype | PMID:37023647 |
| GO:0035847 | Uterine epithelium development | Increases phenotype | PMID:27473340 |
| GO:0035937 | Estrogen secretion | Affects phenotype | PMID:37182577 |
| GO:0040015 | Negative regulation of multicellular organism growth | Increases phenotype | PMID:34134381 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:27567155 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:36881955 |
| GO:0042554 | Superoxide anion generation | Affects phenotype | PMID:33662508 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:37182577 |
| GO:0042816 | Vitamin b6 metabolic process | Affects phenotype | PMID:37094511 |
| GO:0042866 | Pyruvate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:35940389 |
| GO:0043648 | Dicarboxylic acid metabolic process | Affects phenotype | PMID:37094511 |
| GO:0043929 | Primary ovarian follicle growth involved in double layer follicle stage | Decreases phenotype | PMID:30675821 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:30590302; PMID:31059536; PMID:31812737; PMID:32244372; PMID:33662508; PMID:34748853; PMID:37182577; PMID:37715983; PMID:38211720 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:28858478; PMID:31059536 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:31059536; PMID:38211720 |
| GO:0045066 | Regulatory t cell differentiation | Affects phenotype | PMID:37023647 |
| GO:0045333 | Cellular respiration | Affects phenotype | PMID:31596606; PMID:37094511 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:31981723 |
| GO:0045444 | Fat cell differentiation | Affects phenotype | PMID:34186270 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:34134381 |
| GO:0045833 | Negative regulation of lipid metabolic process | Increases phenotype | PMID:39151878 |
| GO:0046031 | Adp metabolic process | Affects phenotype | PMID:37094511 |
| GO:0046083 | Adenine metabolic process | Affects phenotype | PMID:37094511 |
| GO:0046110 | Xanthine metabolic process | Affects phenotype | PMID:37094511 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:30675821 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:27473340 |
| GO:0048477 | Oogenesis | Affects phenotype | PMID:36464114 |
| GO:0048666 | Neuron development | Decreases phenotype | PMID:37023647 |
| GO:0051309 | Female meiosis chromosome separation | Affects phenotype | PMID:36464114 |
| GO:0051321 | Meiotic cell cycle | Affects phenotype | PMID:36464114 |
| GO:0051332 | Meiotic s phase | Affects phenotype | PMID:36464114 |
| GO:0051726 | Regulation of cell cycle | Increases phenotype | PMID:31750923 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:37094511 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:28858478 |
| GO:0060009 | Sertoli cell development | Decreases phenotype | PMID:37216864 |
| GO:0061370 | Testosterone biosynthetic process | Increases phenotype | PMID:27567155; PMID:35605789; PMID:36098747; PMID:37216864; PMID:39938710 |
| GO:0070059 | Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | Increases phenotype | PMID:35940389 |
| GO:0070266 | Necroptotic process | Increases phenotype | PMID:33662508 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:35940389 |
| GO:0071466 | Cellular response to xenobiotic stimulus | Affects phenotype | PMID:30145421 |
| GO:0072520 | Seminiferous tubule development | Decreases phenotype | PMID:36098747; PMID:37216864 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:33662508; PMID:34748853; PMID:34748853; PMID:38211720; PMID:38211720 |
| GO:0097045 | Phosphatidylserine exposure on blood platelet | Increases phenotype | PMID:33662508 |
| GO:0097722 | Sperm motility | Increases phenotype | PMID:32508751 |
| GO:0099563 | Modification of synaptic structure | Increases phenotype | PMID:37023647 |
| GO:0110053 | Regulation of actin filament organization | Affects phenotype | PMID:31750923 |
| GO:0140013 | Meiotic nuclear division | Affects phenotype | PMID:35605789 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:32763284 |
| GO:0140059 | Dendrite arborization | Decreases phenotype | PMID:34134381 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:38043716 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Decreases phenotype | PMID:28259788 |
| GO:1901726 | Negative regulation of histone deacetylase activity | Increases phenotype | PMID:36534918 |
| GO:1902110 | Positive regulation of mitochondrial membrane permeability involved in apoptotic process | Increases phenotype | PMID:35940389 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:39151878 |
| GO:1902951 | Negative regulation of dendritic spine maintenance | Increases phenotype | PMID:34134381 |
| GO:1903046 | Meiotic cell cycle process | Affects phenotype | PMID:36464114 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:38211720 |
| GO:1903353 | Regulation of nucleus organization | Affects phenotype | PMID:31750923 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:30590302 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28259788; PMID:34174261; PMID:39059691 |
| GO:1903709 | Uterine gland development | Increases phenotype | PMID:27473340; PMID:36881955 |
| GO:1903966 | Monounsaturated fatty acid biosynthetic process | Affects phenotype | PMID:30145421 |
| GO:1990138 | Neuron projection extension | Decreases phenotype | PMID:31812737 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:29575470 |
| GO:2000278 | Regulation of dna biosynthetic process | Affects phenotype | PMID:31750923 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:27567155 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:38043716 |
| GO:2000871 | Negative regulation of progesterone secretion | Increases phenotype | PMID:30675821; PMID:38043716 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.